Mitralign Obtains $1,900,000 New Financing

  • Feed Type
  • Date
    10/29/2012
  • Company Name
    Mitralign
  • Mailing Address
    3 Highwood Drive Tewksbury, MA 01876
  • Company Description
    We are currently developing an innovative, catheter-based mitral valve repair system that not only provides an alternative to open heart surgery but emulates the traditional surgical repair technique.

    The condition treated, mitral valve regurgitation (MR), is common in patients with Congestive Heart Failure. Clinical studies have proven that MR significantly increases the risk of mortality in patients afflicted with CHF, a disease affecting 25 Million worldwide. Studies hence recommend earlier treatment of MR in these patients.

  • Website
    http://www.mitralign.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,900,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.